WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...
- Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two years of treatment - - Phase III studies for fenebrutinib in ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will showcase key real-world, product and pipeline data from its ophthalmology portfolio at the Association ...
– Petrelintide achieved up to 10.7% mean body weight reduction at week 42 versus 1.7% with placebo (p-value<0.001) while demonstrating placebo-like tolerability – – At the maximally effective dose, ...
Following an extensive inspection, the Environmental Protection Agency fined Genentech more than $158,000 for hazardous waste violations at a facility in California, the latest instance in which a ...
Genentech, a drugmaker based in South San Francisco, is laying off 93 more local workers just months after a 436-worker cut. The company, which is owned by Swiss pharmaceutical giant Roche, announced ...
June 30 (Reuters) - Genentech will withdraw Gavreto from use in the United States for treating a type of thyroid cancer as it was not feasible for the Roche (ROG.S), opens new tab unit to pursue the ...
Focusing on the 'sandwich generation' - adults caring for ageing parents while raising children - this impactful film from ...
Over the past day, Genentech has been making a concerted bid to expand its partnered portfolio into the hottest R&D areas. Only hours after the Roche unit signed a radiopharmaceutical-focused pact ...
Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/precigen-sees-q1-revenue-exceeding-18m-consensus-20-8m ...
March 1 (Reuters) - Roche's Genentech Inc (ROGING.UL) sued Biogen MA Inc on Tuesday in San Francisco federal court, claiming Biogen owes additional patent royalties from worldwide sales of its ...